Buy (150 RUB)
Generate QR code
Open Access
Subscription or Fee Access
Pituitary adenoma. Clinical case
https://doi.org/10.33667/2078-5631-2024-2-47-49
Abstract
The article describes a clinical case of pituitary adenoma. It is known, that a pituitary adenoma is a benign tumor formation emanating from the glandular tissue of the anterior pituitary gland. Its growth is accompanied by endocrine, neurological and neuro-ophthalmological complications, which is a serious problem in modern neurosurgery due to the involvement of the most important anatomical structures in the pathological process and makes radical tumor resection difficult with a minimum number of complications.
About the Authors
Yu. V. Boldyreva
Tyumen State Medical University
Russian Federation
Russian Federation
Boldyreva Yulia V. - PhD Med, associate professor at Dept of Biological Chemistry at the Institute of Pharmacy.
Tyumen
I. A. Lebedev
Tyumen State Medical University
Russian Federation
Russian Federation
Lebedev Ilya A. - DM Sci (habil.), professor at Dept of Topographic Anatomy and Operative Surgery with a Course of Osteopathy at the Institute of Fundamental.
Tyumen
R. A. Sobinov
Tyumen State Medical University
Russian Federation
Russian Federation
Sobinov Ruslan A. - third year student
Tyumen
E. A. Gavrilenko
Tyumen State Medical University
Russian Federation
Russian Federation
Gavrilenko Elena A. - 4th year student.
Tyumen
Yu. A. Vakulenko
Tyumen State Medical University
Russian Federation
Russian Federation
Vakulenko Yulia A. - 3rd year student.
Tyumen
References
1. Lipatenkova A. K., Dzeranova L. K., Pigarova E. A., Astaf’eva L.I., Grigor’ev A. Ju., Shishkina L. V., Cherebilo V. Ju., Jektova A. P. Silent pituitary adenomas: review and clinical cases. Ozhirenie i metabolism – Obesity and metabolism. 2015; 12 (2): 40–46 (in Russ.).
2. Kalinin P. L., Trunin Ju. Ju., Fomichev D. V., Chernov I. V., Ryzhova M. V. Aggressive forms of pituitary adenomas (literature review and clinical observation). Opuholi golovy i shei – Head and neck tumors. 2017; 7 (4): 74–80 (in Russ.).
3. Dai C., Feng M., Liu X. et al. Refractory pituitary adenoma: a novel classification for pituitary tumors. Oncotarget. 2016; 7 (50): 83657–83668. DOI: 10.18632/oncotarget.13274.
4. Dillard T. H., Gultekin S. H., Delashaw J. B. Jr. et al. Temozolomide for corticotroph pituitary adenomas refractory to standard therapy. Pituitary. 2011; 14 (1): 80–91. DOI: 10.1007/s11102–010–0264–1.
5. Priola S. M., Esposito F., Cannavò S. et al. Aggressive pituitary adenomas: the dark side of the moon. World Neurosurg. 2017; 97: 140–155. DOI: 10.1016/j.wneu.2016.09.092.
6. Liu J. K., Patel J., Eloy J. A. The role of temozolomide in the treatment of aggressive pituitary tumors. J Clin Neurosci. 2015; 22 (6): 923–929. DOI: 10.1016/j.jocn.2014.12.007.
7. Chiloiro S., Doglietto F., Trapasso B. et al. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis. Neuroendocrinology. 2015; 101 (2): 143–150. DOI: 10.1159/000375448.
8. Zaidi H. A., Cote D. J., Dunn I. F., Laws E. R. Jr. Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas. J Clin Neurosci. 2016; 34: 246–251. DOI: 10.1016/j.jocn.2016.09.014.
Review
For citations:
Boldyreva Yu.V., Lebedev I.A., Sobinov R.A., Gavrilenko E.A., Vakulenko Yu.A. Pituitary adenoma. Clinical case. Neurology and psychiatry (1). 2024;(2):47-49. (In Russ.) https://doi.org/10.33667/2078-5631-2024-2-47-49
Views:
208
Email this article 